Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,273,953
  • Shares Outstanding, K 48,110
  • Annual Sales, $ 0 K
  • Annual Income, $ -97,220 K
  • EBIT $ -135 M
  • EBITDA $ -133 M
  • 60-Month Beta -0.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.26

Options Overview Details

View History
  • Implied Volatility 473.90% ( -6.86%)
  • Historical Volatility 103.53%
  • IV Percentile 99%
  • IV Rank 98.35%
  • IV High 480.77% on 11/21/24
  • IV Low 64.13% on 03/27/24
  • Put/Call Vol Ratio 1.18
  • Today's Volume 44,129
  • Volume Avg (30-Day) 15,932
  • Put/Call OI Ratio 1.64
  • Today's Open Interest 282,678
  • Open Int (30-Day) 248,812

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 1
  • High Estimate -0.36
  • Low Estimate -0.36
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +28.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.45 +12.92%
on 11/05/24
33.98 -22.07%
on 11/21/24
-1.95 (-6.86%)
since 10/22/24
3-Month
23.45 +12.92%
on 11/05/24
33.98 -22.07%
on 11/21/24
-3.36 (-11.26%)
since 08/22/24
52-Week
8.79 +201.25%
on 06/28/24
42.20 -37.25%
on 08/05/24
+5.20 (+24.44%)
since 11/22/23

Most Recent Stories

More News
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer to Advance Alzheimer's Treatment Strategy

Cassava Sciences appoints Freda Nassif as Chief Commercial Officer, enhancing its strategy ahead of Phase 3 trial results for Alzheimer's treatment.Quiver AI SummaryCassava Sciences has appointed Freda...

SAVA : 26.48 (-17.71%)
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

SAVA : 26.48 (-17.71%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 6.65 (-2.06%)
LLY : 748.01 (-0.25%)
INMB : 4.87 (+2.31%)
XBI : 96.24 (+2.06%)
BIIB : 157.90 (-0.07%)
SAVA : 26.48 (-17.71%)
A High-potential Bull Put Strategy on Cassava Sciences

This Bull Put strategy has a 76.9% chance of profiting, with a low risk/reward ratio!

SAVA : 26.48 (-17.71%)
Cassava Sciences Reports Q3 2024 Financial and Operating Results

SAVA : 26.48 (-17.71%)
Riot Platforms, Beyond Inc, Globalstar Among Small-Caps On Retail’s Radar As Russell 200 Index Rallies To 3-Year High Following Trump’s Victory

Small-caps, which are relatively more sensitive to the vagaries of the economic environment, are playing catchup with their larger counterparts.

MARA : 26.03 (+7.65%)
FCEL : 8.28 (+4.55%)
BLNK : 1.5300 (+0.66%)
SPCE : 7.15 (+6.40%)
BYON : 5.73 (-0.35%)
RIOT : 12.31 (+4.68%)
IWM : 238.77 (+1.85%)
GSAT : 1.7900 (+1.13%)
CLSK : 15.10 (+16.47%)
SAVA : 26.48 (-17.71%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Small biotech firms like Cassava Sciences, INmune Bio, and Annovis Bio are developing innovative Alzheimer’s treatments, disrupting big pharma’s dominance in the $13.7B market. For those targeting...

ANVS : 6.65 (-2.06%)
LLY : 748.01 (-0.25%)
INMB : 4.87 (+2.31%)
XBI : 96.24 (+2.06%)
BIIB : 157.90 (-0.07%)
SAVA : 26.48 (-17.71%)
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

SAVA : 26.48 (-17.71%)
Analysts Believe Cassava Sciences Now Has 300% Upside From Here

Cassava Sciences faces controversy over its Alzheimer's drug, simufilam, amid fraud allegations, yet analysts maintain a Buy rating with high upside potential.

SAVA : 26.48 (-17.71%)
SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims

Cassava Sciences SAVA has agreed to pay a $40 million fine to settle charges from the U.S. Securities and Exchange Commission (SEC) over allegedly misleading statements about the results of its 2020 mid-stage...

KRYS : 190.40 (+4.45%)
FULC : 3.25 (+9.43%)
ANIP : 56.91 (+1.88%)
SAVA : 26.48 (-17.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 35.29
2nd Resistance Point 33.35
1st Resistance Point 29.91
Last Price 26.48
1st Support Level 24.53
2nd Support Level 22.59
3rd Support Level 19.15

See More

52-Week High 42.20
Fibonacci 61.8% 29.44
Last Price 26.48
Fibonacci 50% 25.50
Fibonacci 38.2% 21.55
52-Week Low 8.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar